Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02402829 · ClinicalTrials.gov registry record
A Study Comparing Factor Level and Inhibitor Titer Testing Results Drawn From Central Venous Lines and Venipuncture
A clinical trial, sponsored by Children's Mercy Hospital Kansas City.
- Terminated
- Registry status
- 3
- Enrollment target
NCT02402829: Clinical Trial study, sponsored by Children's Mercy Hospital Kansas City.
NCT02402829 is a clinical trial that was terminated before completion, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02402829 was terminated before completion, sponsored by Children's Mercy Hospital Kansas City.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
The purpose of this research study is to see if factor levels and inhibitor levels in Hemophilia A and B subjects are accurate when they are drawn from a central venous line (CVL) instead of from a peripheral stick.
Interventions
- PROCEDURE Peripheral Vein Blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2014-11 |
| Est. Completion | 2018-11-28 |
Why NCT02402829 stopped before completion
NCT02402829 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Peripheral Vein Blood draw is the first listed.
NCT02402829 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02402829 about?
NCT02402829 is a clinical study titled "A Study Comparing Factor Level and Inhibitor Titer Testing Results Drawn From Central Venous Lines and Venipuncture". The purpose of this research study is to see if factor levels and inhibitor levels in Hemophilia A and B subjects are accurate when they are drawn from a central venous line (CVL) instead of from a peripheral stick.
What is the current status of trial NCT02402829?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2014-11. Estimated completion is 2018-11-28.
What interventions are being tested in trial NCT02402829?
The interventions under investigation include: Peripheral Vein Blood draw (PROCEDURE).
Who is sponsoring clinical trial NCT02402829?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia